DBV Technologies Announces Resignation of Board Member

Stock Information for Anixa Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Anixa Biosciences Inc.

DBV Technologies Reports Third Quarter 2025 Financial Results
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
DBV Technologies announces filing of 2025 Half-Year Report - Conditions for accessing or consulting the Report
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.